(Q34236115)

English

Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Johanna I P de Vries

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

M G van Pampus

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

W M Hague

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

P D Bezemer

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

J H Joosten

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

FRUIT Investigators

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

64-72

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

Antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

Protein C: comparison of different assays in normal and abnormal plasma samples

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

The simultaneous measurement of total and free protein S by ELISA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

Relationship between thrombophilic disorders and type of severe early-onset hypertensive disorder of pregnancy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

Local retention versus systemic release of soluble VEGF receptor-1 are mediated by heparin-binding and regulated by heparanase.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

Aspirin plus heparin or aspirin alone in women with recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04553.X

21 January 2018

Identifiers

10.1111/J.1538-7836.2011.04553.X

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34236115&oldid=1752740907"